Closer to Cure: Renewed Funding for Type 1 Diabetes UK Immunotherapy Consortium (T1D UK)
More than 400,000 people in the United Kingdom and 1.25 million Americans have type 1 diabetes (T1D), a disease for…
Want to Stave Off Type 1 Diabetes? Beta Cell Proliferation May Be the Key
In Nature Metabolism, Breakthrough T1D-funded researchers—including the lead author, Ercument Dirice, Ph.D., and senior author, Rohit Kulkarni, M.D., Ph.D.—found an…
A DIY Approach to Artificial Pancreas Technology
What do Aaron Kowalski, Ph.D., president and CEO of Breakthrough T1D, and Jeremy Pettus, M.D., an endocrinologist at the University…
Breakthrough T1D Expresses Profound Loss at the Passing of Helaine Shiff, co-founder of Breakthrough T1D Canada
Breakthrough T1D International is deeply saddened at the loss of one of Breakthrough T1D Canada’s co-founders, Helaine Shiff. “Helaine was…
A Win for the European T1D Community: Zynquista (sotagliflozin) Approved for Type 1 Diabetes
In a second win for the type 1 diabetes (T1D) community, the European Commission has approved Zynquista™ (sotagliflozin) for use…
End-Stage Kidney Disease: A Possible Biomarker of 10-Year Risk—and Therapeutic Target—for People with T1D
In the United States, diabetic kidney disease, or DKD, is responsible for more than half of all new cases of…
What is nPOD?
The human pancreas is very difficult to study, as Breakthrough T1D-funded scientists well know. It cannot be imaged or safely…
Breakthrough T1D Names Aaron Kowalski New President and CEO
Chief Mission Officer to assume leadership baton from Derek Rapp After a thorough national search, the Breakthrough T1D International Board…
Breakthrough T1D Nurtures the Young Adult Community by Hosting Networking Conference and Helping Secure Key Internships
More than 120 Young Adults joined Breakthrough T1D for a weekend of networking, learning and connecting at the Breakthrough T1D…
Breakthrough T1D Leaders Jeff Plumer and Sanjoy Dutta Join Editorial Advisory Boards of Two Top Diabetes Publications
Two of the world’s most respected and trusted health publications have tapped Breakthrough T1D to serve as an expert voice…
